Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) traded up 5.8% during trading on Tuesday . The company traded as high as $33.40 and last traded at $33.26. 227,891 shares changed hands during trading, a decline of 63% from the average session volume of 612,261 shares. The stock had previously closed at $31.43. Analysts Set New […]
Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) have been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12-month price objective among brokerages that have issued a report on the stock […]
Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) traded up 2.9% on Wednesday . The company traded as high as $32.18 and last traded at $31.95. 122,738 shares were traded during mid-day trading, a decline of 80% from the average session volume of 617,408 shares. The stock had previously closed at $31.05. Wall Street […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) major shareholder A2a Pharmaceuticals, Inc. sold 25,000 shares of the stock in a transaction on Friday, May 12th. The shares were sold at an average price of $33.84, for a total transaction of $846,000.00. Following the completion of the transaction, the insider now owns 3,625,000 shares of the […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) was the target of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 6,080,000 shares, an increase of 28.5% from the April 15th total of 4,730,000 shares. Based on an average daily trading volume, of 866,700 shares, […]